Steven Busschots

In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies

Martina S.J. McDermott, Alex J. Eustace, Steven Busschots et al. · Frontiers in Oncology · 2014 · 307 citations · Full text

Chemoprevention Strategy, Metronomic Chemotherapy, Cancer Chemotherapy +19

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

Britta Stordal, Kirsten M. Timms, Angela M. Farrelly et al. · Molecular Oncology · 2013 · 144 citations · Full text

PARP Inhibitors as P-glyoprotein Substrates

Denise Lawlor, P.J. Martin, Steven Busschots et al. · Journal of Pharmaceutical Sciences · 2014 · 85 citations

Protein Function, Biochemistry, Medicine +5

Non-invasive and non-destructive measurements of confluence in cultured adherent cell lines

Steven Busschots, Sharon O’Toole, John O’Leary et al. · MethodsX · 2014 · 42 citations · Full text

Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells

Steven Busschots, Sharon O’Toole, John O’Leary et al. · Experimental Cell Research · 2014 · 17 citations · Full text

Medicine, Cancer Biology, Functional Brca1 +9